» Articles » PMID: 17280803

Overdose After Detoxification: a Prospective Study

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2007 Feb 7
PMID 17280803
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study was to determine predictors of non-fatal overdose (OD) among a cohort of 470 adults after detoxification from heroin, cocaine or alcohol.

Methods: We examined factors associated with time to OD during 2 years after discharge from an urban detoxification unit in Boston, MA, USA using multivariable regression analyses. Separate analyses were performed for both the total sample and a subgroup with problem opioid use.

Results: Lifetime prevalence for any OD was 30.9% (145/470) in the total sample and 42.3% (85/201) in patients with opioid problems. During the 2-year follow-up, OD was estimated to occur in 16.9% of the total sample and 26.7% of the opioid problem subgroup, with new-onset (incidence) OD estimated at 5.7% and 11.0%, respectively. Factors associated with an increased hazard of OD in both samples included white race, more depressive symptoms, and prior OD regardless of intent. Prior suicidal ideation or attempt was not associated with future OD.

Conclusions: Findings underscore both the high prevalence of non-fatal OD among detoxification patients especially opioid users, and the potency of prior OD as a risk factor for future OD. Depressive symptoms, a modifiable risk factor, may represent a potential intervention target to prevent OD, including some "unintentional" ODs.

Citing Articles

Geographic and Racial/Ethnic Differences in Access to Methamphetamine Detoxification Services, United States, 2021.

Pro G, Cantor J, Buttram M, Brown C, Gu M, Mancino M Med Care. 2024; 62(7):464-472.

PMID: 38761164 PMC: 11834168. DOI: 10.1097/MLR.0000000000002013.


"They make it too hard and too many hoops to jump": system and organizational barriers to drug treatment during epidemic rates of opioid overdose.

Dickson-Gomez J, Krechel S, Ohlrich J, Montaque H, Weeks M, Li J Harm Reduct J. 2024; 21(1):52.

PMID: 38413972 PMC: 10900746. DOI: 10.1186/s12954-024-00964-5.


Insurance barriers to substance use disorder treatment after passage of mental health and addiction parity laws and the affordable care act: A qualitative analysis.

Dickson-Gomez J, Weeks M, Green D, Boutouis S, Galletly C, Christenson E Drug Alcohol Depend Rep. 2023; 3:100051.

PMID: 36845978 PMC: 9948907. DOI: 10.1016/j.dadr.2022.100051.


Correlates of recent overdose among people who inject drugs in the San Diego/Tijuana border region.

Bailey K, Abramovitz D, Patterson T, Harvey-Vera A, Vera C, Rangel M Drug Alcohol Depend. 2022; 240:109644.

PMID: 36179507 PMC: 9608984. DOI: 10.1016/j.drugalcdep.2022.109644.


Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper.

Bozinoff N, Men S, Kurdyak P, Selby P, Gomes T JAMA Netw Open. 2022; 5(9):e2234168.

PMID: 36173629 PMC: 9523505. DOI: 10.1001/jamanetworkopen.2022.34168.